BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10246080)

  • 1. Drug Enforcement Administration--controlled substances in emergency kits for long term care facilities. Statement of policy.
    Fed Regist; 1980 Apr; 45(70):24128. PubMed ID: 10246080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescriptions for Schedule II controlled substances: Drug Enforcement Administration, Justice. Notice of proposed rulemaking.
    Fed Regist; 1980 Apr; 45(70):24199-200. PubMed ID: 10246081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing the accumulation of surplus controlled substances at long term care facilities. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 May; 70(92):25462-6. PubMed ID: 15892213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled substances in long-term care pharmacy: part 2.
    Martin CM
    Consult Pharm; 2008 Oct; 23(10):742-56. PubMed ID: 19032014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration. Notice of proposed rulemaking.
    Fed Regist; 1982 Sep; 47(181):41140. PubMed ID: 10262071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEA enforcement in long-term care: is a collaborative correction feasible?
    Elon RD; Schlosberg C; Levenson S; Brandt N
    J Am Med Dir Assoc; 2011 May; 12(4):263-9. PubMed ID: 21527167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescriptions; dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration, Justice. Withdrawal of proposed rule.
    Fed Regist; 1983 Jun; 48(125):29713-4. PubMed ID: 10261481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug enforcement administration guidance on use of long-term care facility staff as agents in prescribing some, but not all, controlled drugs.
    Sollins HL
    Geriatr Nurs; 2011; 32(1):49-51. PubMed ID: 21208685
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug Enforcement Administration--Records and reports of registrants; central recordkeeping permits. Final rule.
    Fed Regist; 1980 Jul; 45(128 Pt 1):44266-7. PubMed ID: 10247077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1991 Jun; 56(106):25025-7. PubMed ID: 10111144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASHP technical assistance bulletin on use of controlled substances in organized health care settings.
    Am J Hosp Pharm; 1993 Mar; 50(3):489-501. PubMed ID: 8442469
    [No Abstract]   [Full Text] [Related]  

  • 13. Policy statement--guidance for the administration of medication in school.
    Council on School Health
    Pediatrics; 2009 Oct; 124(4):1244-51. PubMed ID: 19786459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Drug Enforcement Agency's position on "constructive transfer" under the Controlled Substances Act.
    Pore RD
    Int J Pharm Compd; 2012; 16(6):446-50. PubMed ID: 23259358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Drug Enforcement Administration guideline for communicating controlled substance prescriptions to pharmacies.
    Drug Enforcement Adminstration U S Department of Justice
    J Pain Palliat Care Pharmacother; 2011; 25(1):83-9. PubMed ID: 21426229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current regulations and modest proposals regarding disposal of unused opioids and other controlled substances.
    Herring ME; Shah SK; Shah SK; Gupta AK
    J Am Osteopath Assoc; 2008 Jul; 108(7):338-43. PubMed ID: 18648027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Financing Administration--requirements for certification of Medicare and Medicaid long term care facilities with repeat deficiencies. Proposed rule.
    Fed Regist; 1980 Mar; 45(52):16505-6. PubMed ID: 10297722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2003 and inclusion of registered nurses in the personnel provision of the critical access hospital emergency services requirement for frontier areas and remote locations. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2002 Dec; 67(251):79965-80184. PubMed ID: 12510665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarification of registration requirements for individual practitioners. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2006 Dec; 71(231):69478-80. PubMed ID: 17171847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.